Skip to main content

Table 1 Demographic and Clinical Characteristics: Patients With Schizophrenia or Bipolar Disorder and Matched Controls, 2019

From: Prescription opioid dispensing patterns among patients with schizophrenia or bipolar disorder

Commercial Databasea 2019

Parameter

Schizophrenia

(N = 4773)

Schizophrenia Controls

(N = 4773)

Bipolar Disorder

(N = 52,780)

Bipolar Disorder Controls

(N = 52,780)

Age, mean (SD), years

39.0 (14.7)

39.0 (14.7)

41.5 (13.6)

41.5 (13.6)

Sex, n (%)

    

 Female

1998 (41.9)

1998 (41.9)

34,683 (65.7)

34,683 (65.7)

 Male

2775 (58.1)

2775 (58.1)

18,097 (34.3)

18,097 (34.3)

Regional division (Commercial database only), n (%)

    

 East North Central

844 (17.7)

761 (15.9)

9544 (18.1)

8696 (16.5)

 East South Central

254 (5.3)

245 (5.1)

3273 (6.2)

2863 (5.4)

 Middle Atlantic

1047 (21.9)

672 (14.1)

8325 (15.8)

7762 (14.7)

 Mountain

190 (4.0)

242 (5.1)

2724 (5.2)

2629 (5.0)

 New England

165 (3.5)

153 (3.2)

2188 (4.2)

1780 (3.4)

 Pacific

345 (7.2)

431 (9.0)

3571 (6.8)

4392 (8.3)

 South Atlantic

890 (18.7)

942 (19.7)

10,002 (19.0)

10,575 (20.0)

 West North Central

253 (5.3)

261 (5.5)

2721 (5.2)

2713 (5.1)

 West South Central

331 (6.9)

551 (11.5)

4757 (9.0)

5668 (10.7)

 Unknown

454 (9.5)

515 (10.8)

5675 (10.8)

5702 (10.8)

CCIb,c

 Mean (SD)

0.25 (0.70)

0.09 (0.41)

0.25 (0.69)

0.10 (0.43)

Non-CCI comorbidities, n (%)c

 Pain

1734 (36.3)

1215 (25.5)

26,064 (49.4)

16,038 (30.4)

 Substance use disorderd

540 (11.3)

39 (0.8)

5570 (10.6)

357 (0.7)

 Nicotine dependence

534 (11.2)

81 (1.7)

4406 (8.4)

949 (1.8)

 Anxiety disorder

1409 (29.5)

289 (6.1)

21,942 (41.6)

4044 (7.7)

 Depressive disorder

1146 (24.0)

224 (4.7)

14,641 (27.7)

3188 (6.0)

 Post-traumatic stress disorder

269 (5.6)

15 (0.3)

4638 (8.8)

245 (0.5)

 Attention-deficit/hyperactivity disorder

274 (5.7)

100 (2.1)

7760 (14.7)

944 (1.8)

 Personality disorder

163 (3.4)

6 (0.1)

2103 (4.0)

35 (0.1)

Medicaid Databasee 2019

Parameter

Schizophrenia

(N = 30,179)

Schizophrenia Controls

(N = 30,179)

Bipolar Disorder

(N = 63,455)

Bipolar Disorder Controls

(N = 63,455)

Age, mean (SD), years

43.4 (12.8)

43.4 (12.8)

39.5 (12.4)

39.5 (12.4)

Sex, n (%)

    

 Female

12,135 (40.2)

12,135 (40.2)

44,925 (70.8)

44,925 (70.8)

 Male

18,044 (59.8)

18,044 (59.8)

18,530 (29.2)

18,530 (29.2)

Race (Medicaid database only), n (%)

 Black

14,569 (48.3)

10,191 (33.8)

12,646 (19.9)

23,223 (36.6)

 White

11,330 (37.5)

14,840 (49.2)

43,239 (68.1)

30,871 (48.7)

 Hispanic

539 (1.8)

797 (2.6)

940 (1.5)

1927 (3.0)

 Other

3295 (10.9)

3564 (11.8)

5875 (9.3)

6345 (10.0)

 Unknown

446 (1.5)

787 (2.6)

755 (1.2)

1089 (1.7)

CCIb,c

 Mean (SD)

0.64 (1.21)

0.31 (0.86)

0.62 (1.09)

0.23 (0.71)

Non-CCI comorbidities, n (%)c

 Pain

14,486 (48.0)

9819 (32.5)

40,721 (64.2)

20,080 (31.6)

 Substance use disordersd

7290 (24.2)

1959 (6.5)

17,049 (26.9)

3199 (5.0)

 Nicotine dependence

9952 (33.0)

3820 (12.7)

22,134 (34.9)

6989 (11.0)

 Anxiety disorders

8763 (29.0)

2896 (9.6)

29,037 (45.8)

6352 (10.0)

 Depressive disorders

8223 (27.3)

2908 (9.6)

20,820 (32.8)

6297 (9.9)

 Post-traumatic stress disorder

2997 (9.9)

458 (1.5)

12,986 (20.5)

1040 (1.6)

 Attention-deficit/hyperactivity disorder

1338 (4.4)

391 (1.3)

8088 (12.8)

912 (1.4)

 Personality disorders

1871 (6.2)

71 (0.2)

4557 (7.2)

157 (0.2)

  1. aRace not available in the Commercial database
  2. bCCI is a weighted score based on the number and the seriousness (scored 1–6) of comorbid diseases; higher scores are associated with a greater risk of mortality [24]
  3. cComorbidities were assessed by ≥1 ICD-9-CM or ICD-10-CM diagnosis code for the particular condition occurring during the baseline period, except for pain (≥2 diagnosis codes)
  4. dNot including nicotine dependence
  5. eRegional division not available in the Medicaid database
  6. CCI Charlson Comorbidity Index